A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants with High-Risk Muscle-Invasive Urothelial Carcinoma After Surgical Resection (Roche WO29636)
Objective of the study (Lay terms): A study comparing atezolizumab (MPDL3280A) versus observation after cystectomy. The goal is to see if patients who are receiving atezolizumab will have less chance of their cancer coming back.
For More Detailed Information, Contact:
